Insider · CIK 0001492647

Almenoff June Sherie

CIK 0001492647 Name as filed on the most recent filing

Filed as Almenoff June Sherie (15)

26 transaction lines · from 15 filings · filed 2011-09-13 to 2025-11-20 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

26 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2025-11-18 P, Open-market purchase Tenax Therapeutics, Inc.TENX 14,280, acquired Open Form 4 filing 0001492647-25-000004
2025-11-18 P, Open-market purchase Tenax Therapeutics, Inc.TENX 14,280, acquired Open Form 4 filing 0001492647-25-000003
2025-11-17 P, Open-market purchase Tenax Therapeutics, Inc.TENX 665, acquired Open Form 4 filing 0001492647-25-000004
2025-11-17 P, Open-market purchase Tenax Therapeutics, Inc.TENX 665, acquired Open Form 4 filing 0001492647-25-000003
2024-11-13 P, Open-market purchase Avalo Therapeutics, Inc.AVTX 6,500, acquired Open Form 4 filing 0001578563-24-000441
2024-11-12 P, Open-market purchase Avalo Therapeutics, Inc.AVTX 6,250, acquired Open Form 4 filing 0001578563-24-000441
2019-01-04 P, Open-market purchase Brainstorm Cell Therapeutics Inc.BCLI 5,000, acquired Open Form 4 filing 0001144204-19-000986
2018-08-27 P, Open-market purchase Innovate Biopharmaceuticals, Inc.INNT 3 lines 1,979, acquired Open Form 4 filing 0001551986-18-000017
2018-08-24 P, Open-market purchase Innovate Biopharmaceuticals, Inc.INNT 3 lines 4,906, acquired Open Form 4 filing 0001551986-18-000017
2018-03-15 P, Open-market purchase Brainstorm Cell Therapeutics Inc.BCLI 19,950, acquired Open Form 4 filing 0001144204-18-015760
2015-02-06 P, Open-market purchase Ohr Pharmaceutical IncOHRP 40,500, acquired Open Form 4 filing 0001387131-15-000429
2014-09-03 P, Open-market purchase Ohr Pharmaceutical IncOHRP 9,660, acquired Open Form 4 filing 0001387131-14-003195
2014-09-02 P, Open-market purchase Ohr Pharmaceutical IncOHRP 8,120, acquired Open Form 4 filing 0001387131-14-003195
2014-06-26 P, Open-market purchase Ohr Pharmaceutical IncOHRP 26,688, acquired Open Form 4 filing 0001387131-14-002346
2014-04-08 P, Open-market purchase Ohr Pharmaceutical IncOHRP 56,375, acquired Open Form 4 filing 0001387131-14-001338
2014-02-04 S, Open-market sale Furiex Pharmaceuticals, Inc.FURX 2 lines 13,271,221, disposed Open Form 4 filing 0001437749-14-001663
2012-08-15 P, Open-market purchase Furiex Pharmaceuticals, Inc.FURX 17,746, acquired Open Form 4 filing 0001181431-12-046074
2012-08-14 P, Open-market purchase Furiex Pharmaceuticals, Inc.FURX 928, acquired Open Form 4 filing 0001181431-12-046074
2012-05-17 P, Open-market purchase Furiex Pharmaceuticals, Inc.FURX 29,600, acquired Open Form 4 filing 0001181431-12-031130
2012-02-24 P, Open-market purchase Furiex Pharmaceuticals, Inc.FURX 54,630, acquired Open Form 4 filing 0001181431-12-012638
2011-09-09 P, Open-market purchase Furiex Pharmaceuticals, Inc.FURX 14,950, acquired Open Form 4 filing 0001181431-11-048952

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 24
  • Open-market sale 2
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Almenoff June Sherie, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001492647

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.